Participants 0 193 5
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403
Participants 330 396 4
experienced, human immunodeficiency virus (HIV)-infected children.
Participants 643 770 7
Forty-one children and youths between 5 months and 21 years with prior NRTI and no prior NNRTI or protease inhibitor experience
Participants 2422 2454 4
HIV-infected children and adults
